loader image
Friday, May 3, 2024
80.4 F
McAllen
We Welcome your Press Release
- Advertisement -

DHR Health Institute for Research and Development Acquires Mobile Research Unit to Treat COVID-19 Patients

Mobile unit to help identify and evaluate potential treatments for non-hospitalized adults with COVID-19

Translate to Spanish or other 102 languages!

Delievery of the Mobile Research Unit

Mega Doctor News

- Advertisement -

Edinburg, Texas – DHR Health Institute for Research and Development announces the arrival of the National Institutes of Health (NIH) Sponsored Mobile Research Unit.  DHR Health Institute for Research and Development is one of nine to be granted a unit by the NIH, allowing the institute to continue their mission to treat COVID-19 patients in the Rio Grande Valley. 

“We are extremely excited to partner with NIH in this initiative and to be only 1 of 9 sites in the US that has been granted by NIH with such capacity-building initiative,” said Sohail Rao, executive vice president, DHR Health and president and CEO DHR Health Institute. “The Mobile Research Unit will be used to enroll thousands of patients and volunteers in large scale clinical trials testing a variety of investigational vaccine, monoclonal antibodies and drugs intended to protect people from COVID-19 and/or treat them for acute and chronic complications of COVID-19”

Through the acquirement of the Mobile Research Unit, DHR Health Institute for Research and Development will expand the capacity to conduct innovative clinical trials that would benefit the residents of the Rio Grande Valley and treat them for chronic complications of COVID-19.  The 38×11.5 unit, that features a nurse practitioner, research nurse coordinator, driver/coordinator, three exam rooms and a lobby, will have access to enroll thousands of patients and volunteers in large clinical trials, testing a variety of investigational vaccines, monoclonal antibodies, and drugs intended to protect people from COVID-19. 

- Advertisement -

The DHR Health Institute for Research and Development is committed to providing access to innovative and advanced clinical care for patients in the Rio Grande Valley and currently has four clinical trials that will be initiated in the mobile unit immediately while other trials are being negotiated.  Committed to enrolling individuals most impacted by COVID-19, DHR Health Institute for Research and Development will work closely with the community to make participation in the trial available to those who qualify for clinical research.  In addition to a modest stipend, transportation services are also available for patients who would like to participate.

For more information about participating in a study, please call DHR Health Institute for Research and Development at 956-362-2393 or visit DHRResearch.org

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Public Health Officials Report First Flu Related Death in El Paso

Influenza (commonly known as flu) is a highly contagious respiratory illness caused by influenza viruses that infect the nose throat and lungs and can result in serious complications such as pneumonia, bacterial infections and even death. 

Publisher’s Word: Dr. Jeffrey Skubic, Offering Hope to Trauma Patients

In a world where seconds can mean the difference between life and death, Dr. Jeffrey Skubic emerges as the light of hope and innovation in trauma care.

Walmart Health & Virtual Health Care Closing

While we will no longer operate health centers, we will take what we learned as we provide trusted health and wellness services across the country through our nearly 4,600 Pharmacies and more than 3,000 Vision Centers

Dr. Jeffrey Skubic, Shaping the Future of Trauma Care

In the high-stakes world of trauma care, where every second can mean the difference between life and death
- Advertisement -
×